跳至主要内容
临床试验/JPRN-UMIN000021383
JPRN-UMIN000021383已完成未知

Investigation of improved Helicobacter pylori eradication rate using Vonoprazan for first-line therapy: large prospective study. - H. pylori eradication rate using Vonoprazan

TT Medical Center Tokyo0 个研究点目标入组 500 人开始时间: 2016年3月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with gastric cancer identified by initial gastroduodenal endoscopy Patients who hava allergy to eraducation drugs Patients who have severe diseases affecting the kidney. Patients who have severe diseases affecting the heart. Patients who have severe diseases affecting the liver. Patients judged as inappropriate candidates for the trial by the investigators

研究者

发起方
TT Medical Center Tokyo

相似试验